Erythrodermic psoriasis peculiarly sparing anti-TNF injection sites in a patient with secondary loss of efficacy

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12551. Epub 2017 Oct 4.

Authors

Dipali Malvankar Kapoor¹, Ki-Wei Tan¹

Affiliation

¹ Department of Dermatology, Changi General Hospital, Singapore.

PMID: 28976682
DOI: 10.1111/dth.12551

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / administration & dosage*
Adult
Dermatitis, Exfoliative / diagnosis
Dermatitis, Exfoliative / drug therapy*
Dermatitis, Exfoliative / immunology
Dermatologic Agents / administration & dosage*
Female
Humans
Injections, Subcutaneous
Psoriasis / diagnosis
Psoriasis / drug therapy*
Psoriasis / immunology
Skin / drug effects*
Skin / immunology
Skin / pathology
Treatment Failure
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology

Substances

Dermatologic Agents
Tumor Necrosis Factor-alpha
Adalimumab